Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2015 2
2016 6
2017 5
2018 9
2019 5
2020 14
2021 10
2022 8
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Evolocumab has no effects on heart failure with reduced ejection fraction injury biomarkers: The EVO-HF trial.
Bayes-Genis A, Lupón J, Revuelta-Lopez E, Llibre C, Gastelurrutia P, Domingo M, Cediel G, Codina P, Santiago-Vacas E, Rangel-Sousa D, Fernández-Cisnal A, Miñana G, Mollar A, Núñez J. Bayes-Genis A, et al. Among authors: mollar a. Eur J Heart Fail. 2023 Aug;25(8):1439-1443. doi: 10.1002/ejhf.2932. Epub 2023 Jun 27. Eur J Heart Fail. 2023. PMID: 37323111
Short-term effects of dapagliflozin on maximal functional capacity in heart failure with reduced ejection fraction (DAPA-VO2 ): a randomized clinical trial.
Palau P, Amiguet M, Domínguez E, Sastre C, Mollar A, Seller J, Garcia Pinilla JM, Larumbe A, Valle A, Gómez Doblas JJ, de la Espriella R, Miñana G, Mezcua AR, Santas E, Bodí V, Sanchis J, Pascual-Figal D, Górriz JL, Baýes-Genís A, Núñez J; DAPA-VO2 Investigators (see Appendix). Palau P, et al. Among authors: mollar a. Eur J Heart Fail. 2022 Oct;24(10):1816-1826. doi: 10.1002/ejhf.2560. Epub 2022 Jun 6. Eur J Heart Fail. 2022. PMID: 35604416 Free article. Clinical Trial.
Short-term changes in klotho and FGF23 in heart failure with reduced ejection fraction-a substudy of the DAPA-VO2 study.
Mora-Fernández C, Pérez A, Mollar A, Palau P, Amiguet M, de la Espriella R, Sanchis J, Górriz JL, Soler MJ, Navarro-González JF, Núñez J; DAPA-VO2 Investigators; DAPA-VO Investigators. Mora-Fernández C, et al. Among authors: mollar a. Front Cardiovasc Med. 2023 Aug 25;10:1242108. doi: 10.3389/fcvm.2023.1242108. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37745119 Free PMC article.
Frailty and Hospitalization Burden in Patients With Chronic Heart Failure.
Mollar A, Bonanad C, Diez-Villanueva P, Segarra D, Civera J, Sastre C, Conesa A, Villaescusa A, Fernández J, Miñana G, Navarro J, Sanchis J, Núñez J. Mollar A, et al. Am J Cardiol. 2022 Nov 15;183:48-54. doi: 10.1016/j.amjcard.2022.08.013. Epub 2022 Sep 22. Am J Cardiol. 2022. PMID: 36153181
Homocysteine and long-term recurrent infarction following an acute coronary syndrome.
Miñana G, Gil-Cayuela C, Fácila L, Bodi V, Valero E, Mollar A, Marco M, García-Ballester T, Zorio B, Martí-Cervera J, Núñez E, Chorro FJ, Sanchis J, Núñez J. Miñana G, et al. Among authors: mollar a. Cardiol J. 2021;28(4):598-606. doi: 10.5603/CJ.a2020.0170. Epub 2020 Dec 21. Cardiol J. 2021. PMID: 33346372 Free PMC article.
Efficacy and Safety of Subcutaneous Infusion of Non-formulated Furosemide in Patients with Worsening Heart Failure: a Real-World Study.
Civera J, de la Espriella R, Heredia R, Miñana G, Santas E, Conesa A, Mollar A, Sastre C, Martínez A, Villaescusa A, Núñez J. Civera J, et al. Among authors: mollar a. J Cardiovasc Transl Res. 2022 Jun;15(3):644-652. doi: 10.1007/s12265-021-10173-1. Epub 2021 Oct 12. J Cardiovasc Transl Res. 2022. PMID: 34642870 Free PMC article.
53 results